Tiotropium as a first maintenance drug in COPD: secondary analysis of the UPLIFT (R) trial

Troosters, T.; Celli, B.; Lystig, T.; Kesten, S.; Mehra, MEHMET; Tashkin, D.; Decramer, M.

doi:10.1183/09031936.00127809

Tiotropium as a first maintenance drug in COPD: secondary analysis of the UPLIFT (R) trial

Troosters T., Celli B., Lystig T., Kesten S., Mehra S., Tashkin D. P., ...Daha Fazla

EUROPEAN RESPIRATORY JOURNAL, cilt.36, sa.1, ss.65-73, 2010 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 36 Sayı: 1
Basım Tarihi: 2010
Doi Numarası: 10.1183/09031936.00127809
Dergi Adı: EUROPEAN RESPIRATORY JOURNAL
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.65-73
Anahtar Kelimeler: Anticholinergic agent, chronic obstructive pulmonary disease, disease progression, exacerbation, lung function, quality of life, OBSTRUCTIVE PULMONARY-DISEASE, HEALTH-STATUS, LUNG-FUNCTION, MANAGEMENT, BRONCHITIS, DECLINE
Eskişehir Osmangazi Üniversitesi Adresli: Evet

Özet

The aim of the present study was investigate the long-term effect of tiotropium as first maintenance respiratory medication in chronic obstructive pulmonary disease (COPD).